TransMedics Gr (NASDAQ:TMDX) reported quarterly earnings of $0.44 per share which missed the analyst consensus estimate of $0.47 by 6.38 percent. This is a 52.17 percent decrease over earnings of $0.92 per share from the same period last year. The company reported quarterly sales of $189.948 million which beat the analyst consensus estimate of $183.635 million by 3.44 percent. This is a 20.70 percent increase over sales of $157.370 million the same period last year.